Download the Free Prime PubMed App to your smartphone or tablet.

Available for iPhone or iPad:

Unbound PubMed app for iOS iPhone iPadAlso Available:
Unbound MEDLINE
Unbound PubMed app for Android

Available for Mac and Windows Desktops and laptops:

Unbound PubMed app for Windows
(chemosurgery)
248 results
  • Intra-arterial chemotherapy in retinoblastoma - A paradigm change. [Review]
    Indian J Ophthalmol 2019; 67(6):740-754Manjandavida FP, Stathopoulos C, … Shields CL
  • Intra-arterial chemotherapy (IAC), also known as superselective ophthalmic artery chemotherapy or chemosurgery, is currently widely accepted as one of the primary treatment modalities for intraocular retinoblastoma worldwide. Following the introduction of the technique in 1998, IAC has evolved over the past decades to be safer and more effective. Accumulated evidence shows that IAC is more effect…
  • Symptoms of and Palliative Treatment for Unresectable Skin Cancer. [Review]
    Curr Treat Options Oncol 2019; 20(4):34Goto H, Kiyohara Y, … Yamamoto O
  • The symptom prevalence in patients with advanced cancer depends on the type of primary cancer, and the palliative treatment varies according to the nature of the primary cancer. Palliative treatment for unresectable skin cancer has not been fully discussed. Patients with unresectable skin cancer sometimes show the primary lesion in the skin and metastases to the lung, skin, liver, and bone. Pain,…
  • Current Treatment of Bilateral Retinoblastoma: The Impact of Intraarterial and Intravitreous Chemotherapy. [Journal Article]
    Neoplasia 2018; 20(8):757-763Francis JH, Roosipu N, … Abramson DH
  • CONCLUSIONS: The majority (89%) of bilateral retinoblastoma patients in the current era and at this center were treated with OAC. This has resulted in saving a historic number of eyes. A quarter of eyes developed recurrent disease (defined as recurrent disease requiring any treatment including focal), the majority of which occurred in the first year after treatment, and all but one was saved. There has been no compromise in patient survival.
New Search Next